Nov 30
The drug delayed patients’ worsening by about five months over the course of the study, Japanese drugmaker Eisai’s Dr. Michael Irizarry said.
This is site is run by Sascha Endlicher, M.A., during ungodly late night hours. Wanna know more about him? Connect via Social Media by jumping to about.me/sascha.endlicher.
Post a Comment